Skip to main content
Top
Published in: Clinical Rheumatology 4/2009

01-04-2009 | Brief Report

Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients?

Authors: M. Levitus, A. Pelliccia, R. J. van de Stadt, A. E. Voskuyl, A. A. Bouman

Published in: Clinical Rheumatology | Issue 4/2009

Login to get access

Abstract

Treatment of rheumatoid arthritis (RA) is monitored with the disease activity score (DAS28), for which the erythrocyte sedimentation rate (ESR) is needed. Apart from the original gold standard method, other methods like the Alifax Test-1TH apparatus are widely used in laboratory worldwide. We compared ESR values obtained by the Alifax Test-1Th apparatus and the gold standard method for 218 RA patients. We found a good correlation (r = 0.87) between the Alifax Test-1TH results and the gold standard method. A good correlation (r = 0.96) was also found for the DAS28 results obtained with both methods. The number of patients that were misclassified when the Alifax Test-1TH is used is reasonable for both the ESR (14.7%) and the DAS28 (10.6%). These results suggest that it may be useful to determine the ESR by the Alifax Test-1TH, with a DAS28 misclassification in less than 11% of the patients.
Literature
1.
go back to reference Van der Heijde DM, van’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LB (1990) Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a disease activity score. Ann Reum Dis 49:916–920CrossRef Van der Heijde DM, van’t Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LB (1990) Judging disease activity in clinical practice in rheumatoid arthritis. First step in the development of a disease activity score. Ann Reum Dis 49:916–920CrossRef
2.
go back to reference Van der Heijde DM, van’t Hof MA, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20(3):579–581PubMed Van der Heijde DM, van’t Hof MA, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20(3):579–581PubMed
3.
go back to reference Pincus T, Sokka T (2005) Complexities in the quatitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 23:S1–S9PubMed Pincus T, Sokka T (2005) Complexities in the quatitative assessment of patients with rheumatic diseases in clinical trials and clinical care. Clin Exp Rheumatol 23:S1–S9PubMed
4.
go back to reference Fransen J, van Riel PLCM (2006) Das remission cut points. Clin Exp Rheumatol 24:S29–S32 Fransen J, van Riel PLCM (2006) Das remission cut points. Clin Exp Rheumatol 24:S29–S32
5.
go back to reference Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D (2004) Effect of a strategy for tight control of rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269PubMedCrossRef Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D (2004) Effect of a strategy for tight control of rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263–269PubMedCrossRef
6.
go back to reference Prevoo MML, van Gestel AM, van’t Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PCLM (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101–1105PubMedCrossRef Prevoo MML, van Gestel AM, van’t Hof MA, van Rijswijk MH, van de Putte LBA, van Riel PCLM (1996) Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol 35:1101–1105PubMedCrossRef
7.
go back to reference Westergren A (1921) Studies of the suspension stability of the blood pulmonary tuberculosis. Acta Med Scand 46:198–203 Westergren A (1921) Studies of the suspension stability of the blood pulmonary tuberculosis. Acta Med Scand 46:198–203
8.
go back to reference Passing H, Bablok W (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21(11):709–720PubMed Passing H, Bablok W (1983) A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 21(11):709–720PubMed
9.
go back to reference Passing H, Bablok W (1984) Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J Clin Chem Clin Biochem 22(6):431–445PubMed Passing H, Bablok W (1984) Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part II. J Clin Chem Clin Biochem 22(6):431–445PubMed
10.
go back to reference Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMed Bland JM, Altman DG (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1(8476):307–310PubMed
11.
go back to reference Ledingham J, Deighton C, on behalf of the British Society for Rheumatology Standards GaAWG (SGAWG) (2005) Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 44:157–163PubMedCrossRef Ledingham J, Deighton C, on behalf of the British Society for Rheumatology Standards GaAWG (SGAWG) (2005) Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 44:157–163PubMedCrossRef
12.
go back to reference Fransen J, Creemers MCW, van Riel PCLM (2004) Remission in reumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43(10):1252–1255PubMedCrossRef Fransen J, Creemers MCW, van Riel PCLM (2004) Remission in reumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology 43(10):1252–1255PubMedCrossRef
13.
go back to reference Oosting JD, Pel V, Groenevelt R, Sant van’t P (2003) Karakterisering van de bepaling van de bezinkingssnelheid van erytrocyten met behulp van de Test-1 van Alifax. Ned Tijdschr Klin Chem 28:197–198 Oosting JD, Pel V, Groenevelt R, Sant van’t P (2003) Karakterisering van de bepaling van de bezinkingssnelheid van erytrocyten met behulp van de Test-1 van Alifax. Ned Tijdschr Klin Chem 28:197–198
14.
go back to reference De jonge N, Sewkaransing I, Slinger J, Rijsdijk JJM (2000) Erythrocyte sedimentation by the Test-1 analyzer. Clin Chem 46:881–882PubMed De jonge N, Sewkaransing I, Slinger J, Rijsdijk JJM (2000) Erythrocyte sedimentation by the Test-1 analyzer. Clin Chem 46:881–882PubMed
15.
go back to reference Plebani M, Piva E (2002) Erythrocyte sedimentation rate: use of fresh blood for quality control. Am J Clin Pathol 117(4):621–626PubMedCrossRef Plebani M, Piva E (2002) Erythrocyte sedimentation rate: use of fresh blood for quality control. Am J Clin Pathol 117(4):621–626PubMedCrossRef
Metadata
Title
Is the Alifax Test-1TH useful to determine the Disease Activity Score (DAS28) in rheumatoid arthritis patients?
Authors
M. Levitus
A. Pelliccia
R. J. van de Stadt
A. E. Voskuyl
A. A. Bouman
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2009
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1092-4

Other articles of this Issue 4/2009

Clinical Rheumatology 4/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.